Structural characterization of human hemoglobin crosslinked by bis(3,5- dibromosalicyl) fumarate using mass spectrometric techniques

Protein Science

Volumn 6, Issue 12, 1997, Pages 2568-2577

  Yu, Zhonghua ^a   Friso, Giulia ^a   Miranda, J J ^a   Patel, Mehul J ^b   Lo Tseng, Thomas ^b   Moore, Edwin G ^b   Burlingame, Alma L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Blood substitute; Hemoglobin; Mass spectrometry; Peptide mass mapping; Protein crosslinking; Structural characterization

Indexed keywords

BIS(3,5 DIBROMOSALICYL)FUMARIC ACID; FUMARIC ACID DERIVATIVE; HEME; HEMOGLOBIN; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031440225     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560061209     Document Type: Article

References (22)

1. Amberson WR. 1937. Blood substitutes. Biol Rev 12:48-86.
2. Bunn FH, Esham WT, Bull RW. 1969. The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 129:909-924.
3. Bunn FH, Forget BG. 1986. Hemoglobin: Molecular genetic and clinical aspects. Philadelphia: WB Saunders Co.
4. Burlingame AL, Boyd RK, Gaskell SJ. 1996. Mass spectrometry. Anal Chem 68:599R-651R
5. Chatterjee R, Welty EV, Walder RY, Pruitt ST, Rogers PH, Arnone A, Walders JA. 1986. Isolation and characterization of a new hemoglobin derivative crosslinked between the α chains. J Biol Chem 261:9929-9937.
6. Cole DJ, Schell RM, Drummond JC, Pryzbelski RJ, Marcantonio S. 1993. Focal cerebral ischemia in rats: Effect of hemodilution with α-α crosslinked hemoglobin on brain injury and edema. Can J Neurol Sci 20:30-36.
7. Farmer MC, Pryzbelski RJ, Mckenzie JE, Burhop KE. 1995. Preclinical data and clinical trial with diaspirin crosslinked hemoglobin. In: Tsuchida E, ed. Artificial red cells. New York: John Wiley & Sons Ltd. pp 177-185.
8. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse C. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science 246:64-71.
9. Fernandez EJ. 1995. Crystallographic studies on chemically modified hemoglobin [thesis]. Chicago, IL: Loyola University.
10. Green BN, Oliver RWA, Falick AM, Shackleton CHL, Roitman E, Witkowska HE. 1990. Electrospray MS, LSIMS and MS/MS for the rapid detection and characterization of variant hemoglobins. In: Burlingame AL, McCloskey JA, ed. Biological mass spectrometry. Amsterdam: Elsevier. pp 129-146.
11. Jones RT. 1989. Structural characterization of modified hemoglobins. Methods Enzymol 231:322-343.
12. Karas M, Hillenkamp F. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10.000 daltons. Anal Chem 60:2299.
13. Matsui NM, Smith DM, Clauser KR, Fichmann J, Andrews LE, Sullivan CM, Burlingame AL, Epstein LB. 1997. Immobilized pH gradient two-dimensional gel electrophoresis and mass spectrometric identification of cytokine-regulated proteins in ME-180 cervical carcinoma cells. Electrophoresis 18:409-417.
14. Medzihradszky KF, Gibson BW, Kaur S, Yu Z, Medzihradszky D. Burlingame AL, Bass N. 1992. The primary structure of fatty-acid-binding protein from nurse shark liver. Structural and evolutionary relationship to the mammalian fatty-acid-binding protein family. Ear J Biochem 203: 327-339.
15. Moffat AS. 1991. Three li'l pigs and the hunt for blood substitutes. Science 253:32-34.
16. O'Donnell JK, Martin MJ, Logan JS, Kumar R. 1993. Production of human hemoglobin in transgenic swine: An approach to a blood substitute. Cancer Detection and Prevention 17:307-312.
17. Perutz MF, 1979. Regulation of oxygen affinity of hemoglobin: Influence on structure of the globin on the heme iron. Annu Rev Biochem 48:327-376.
18. Perutz MF, Rossman MG, Cullis AF, Muirhead H, Will G, North ACT. 1960. The structure of haemoglobin. A three dimensional Fourier synthesis at 5.5 Å resolution, obtained by X-ray analysis. Nature 185:416.
19. Roth RI, Levin, J, Chapman KW, Schmeizl M, Rickles FR. 1993. Production of modified crosslinked cell-free hemoglobin for human use: The role of quantitative determination of endotoxin contamination. Transfusion 33:919-924.
20. Shackleton CHL, Witkowska HE. 1996. Characterizing abnormal hemoglobin by MS. Anal Chem News & Features January 1:29A-32A.
21. Snyder SR, Welly EV, Walder RY, Williams LA, Walder JA. 1987. HbXL99a, A hemoglobin derivative that is crosslinked between the α subunits is useful as a blood substitute. Proc Natl Acad Sci USA 84:7280-7284.
22. Vandegriff KD, Medina F, Marini M, Winslow RM. 1989. Equilibrium oxygen binding to human hemoglobin crosslinked between the α chains by bis(3,5-dibromosalicyl) fumarate. J Biol Chem 264:17824-17833.